September 22, 2023 — Innovative Health, Inc. launched a new educational initiative and free online tool to help hospital ...
September 21, 2023 — Many of the nation’s most prominent cardiovascular organizations, representing tens of thousands of ...
September 21, 2023 — Declines in cardiovascular procedure volumes observed early in the COVID-19 pandemic greatly ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
September 21, 2023 — Vektor Medical, developers of the only FDA-cleared technology to accurately map arrhythmias using ...
September 21, 2023 — Heart Test Laboratories, Inc., an AI-powered medical technology company focused on transforming ...
September 20, 2023 — Orchestra BioMed Holdings, Inc., a biomedical company accelerating high-impact technologies to ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
September 20, 2023 — The Minneapolis Heart Institute Foundation (MHIF), an internationally renowned cardiovascular ...
September 20, 2023 — The U.S. Preventive Services Task Force (Task Force) published a final recommendation statement on ...
September 19, 2023 — SmartCardia has received FDA clearance for its 7-lead real-time ECG monitoring patch and cloud ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
September 19, 2023 — An advanced CT test can identify individuals with stable angina at a reduced risk of three-year ...
September 19, 2023 — A mathematical and computational model of the human heart entirely developed at Politecnico di ...
September 18, 2023 — Pregnant women with a history of substance abuse face a dramatically increased risk of death from ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
September 18, 2023 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & ...
September 18, 2023 — Anthos Therapeutics, Inc., a clinical stage company developing innovative therapies for ...
September 15, 2023 — A team of interventional cardiologists from Henry Ford Health’s Center for Structural Heart Disease ...